EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

State of the art treatment with Impella® in cardiac surgery in Austria

Dominik Wiedemann, Julia Dumfarth, Andreas F Zierer, Daniel Zimpfer

Wiener klinische Wochenschrift · 2024

DOI: 10.1007/s00508-024-02408-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Wiener klinische Wochenschrift, 2024. Verfasst von Dominik Wiedemann und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery University Hospital St. Pölten, Karl Landsteiner University of Health Sciences, St. Pölten and Krems, Austria. Dominik.Wi…. Hauptthemen laut MEDLINE: Cardiac Surgical Procedures, Heart-Assist Devices. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karl Landsteiner Privatuniversität für Gesundheitswissenschaften.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since 2022, the mechanical left ventricular support system Impella 5.5® has been used in Austria for patients with cardiogenic shock, advanced heart failure, post-cardiotomy and low output syndrome. The surgical insertion of the Impella 5.5 via the subclavian artery or alternatively via the ascending aorta has become an established procedure for medium-term treatment in patients with cardiogenic shock and bridging scenarios, such as bridge to recovery, bridge to left ventricular assist device (LVAD), bridge to decision, and bridge to heart transplant (HTx) in Austria. All Impella left ventricular heart pumps share the common feature of unloading the left ventricle, with the Impella 5.5 achieving a full cardiac output of 5.5 l/min. The stable positioning via transaxillary or transaortic insertion enables rapid extubation and mobilization of patients in the intensive care unit (ICU), leading to a significantly shorter ICU stay. The combined support of Impella 5.5 with venoarterial extracorporeal membrane oxygenation (VA-ECMO) has also proven effective in certain scenarios. Several nonrandomized studies demonstrated the effectiveness and safety of the Impella 5.5 in practice, which have been included in multiple international guidelines. The advantages of the Impella 5.5 in practice include the easy handling with high positional stability, and low complications rates. This article describes the significance of surgical Impella treatment in Austria from the perspective of Austrian clinical experts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac Surgical ProceduresHeart-Assist DevicesHumansAustriaHeart FailureShock, CardiogenicTreatment Outcome

Stichwörter der Autor:innen

Heart failureHeart recoveryImpellaMechanical circulatory supportMedium-term cardiac support

Autor:innen und Institutionen

  • Division of Cardiac Surgery University Hospital St. Pölten, Karl Landsteiner University of Health Sciences, St. Pölten and Krems, Austria. Dominik.Wiedemann@stpoelten.lknoe.at.
  • Department of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.
  • Department of Cardio-Thoracic and Vascular Surgery, Johannes Kepler University Hospital Linz, Linz, Austria.
  • Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Förderung

  • Karl Landsteiner Privatuniversität für Gesundheitswissenschaften

Zitieren

APA

Wiedemann, D., Dumfarth, J., Zierer, A. F., & Zimpfer, D. (2024). State of the art treatment with Impella® in cardiac surgery in Austria. Wiener klinische Wochenschrift. https://doi.org/10.1007/s00508-024-02408-3

Vancouver

Wiedemann D, Dumfarth J, Zierer AF, Zimpfer D. State of the art treatment with Impella® in cardiac surgery in Austria. Wiener klinische Wochenschrift. 2024. doi:10.1007/s00508-024-02408-3

BibTeX
@article{Wiedemann2024,
  author = {Wiedemann, Dominik and Dumfarth, Julia and Zierer, Andreas F and Zimpfer, Daniel},
  title = {State of the art treatment with Impella® in cardiac surgery in Austria},
  journal = {Wiener klinische Wochenschrift},
  year = {2024},
  doi = {10.1007/s00508-024-02408-3}
}
Kostenlos starten →